Kiel E A, Drummond W H, Barrett D J
Am J Dis Child. 1984 Feb;138(2):143-6. doi: 10.1001/archpedi.1984.02140400029007.
Thirty-two infants younger than 6 months with catheterization-proved congenital heart disease were prospectively examined for T-lymphocyte immunodeficiency (compared with adult and normal newborn controls). Cardiac lesions were separated into two groups: (1) "high-risk" lesions previously associated with T-cell abnormalities in DiGeorge's syndrome, and (2) the remaining "low-risk" lesions. Cardiac patients as a whole did not have significant abnormalities in T-cell rosette (TCR) percentages (mean +/- SE, 50.0% +/- 22%) or response to phytohemagglutinin (PHA) (72,243 +/- 38,388 counts per minute). However, a greater percentage of patients with high-risk cardiac lesions had abnormal TCR and PHA results than either the control or low-risk group, due to the inclusion of three infants with DiGeorge's syndrome. These findings suggest that newborn infants without evidence of DiGeorge's syndrome have normal T-lymphocyte function. Infants with high-risk cardiac lesions deserve a careful immunologic evaluation to avoid significant morbidity and mortality.
对32名6个月以下经心导管检查证实患有先天性心脏病的婴儿进行了前瞻性研究,以检测T淋巴细胞免疫缺陷(与成人及正常新生儿对照组相比)。心脏病变分为两组:(1)先前在迪格奥尔格综合征中与T细胞异常相关的“高危”病变;(2)其余的“低危”病变。总体而言,心脏病患者的T细胞玫瑰花结(TCR)百分比(均值±标准误,50.0%±2.2%)或对植物血凝素(PHA)的反应(每分钟72,243±38,388计数)并无显著异常。然而,由于纳入了三名患有迪格奥尔格综合征的婴儿,高危心脏病变患者中TCR和PHA结果异常的比例高于对照组或低危组。这些发现表明,无迪格奥尔格综合征证据的新生儿具有正常的T淋巴细胞功能。患有高危心脏病变的婴儿值得进行仔细的免疫学评估,以避免严重的发病率和死亡率。